BioNTech Announces Appointment of Guido Oelkers to Management Board as Chief Executive Officer
BioNTech SE announced the appointment of Guido Oelkers, Ph.D., as its new Chief Executive Officer effective by February 2027. Oelkers will succeed co-founder Prof. Ugur Sahin and bring over 30 years of experience leading biopharmaceutical companies, including a successful tenure as CEO at Swedish Orphan Biovitrum AB. The leadership change aligns wi…